AlbionVentures

Dexela

Founded in 2005 to address significant unmet medical need in the early detection of breast cancer, Dexela is developing innovative, low-radiation imaging techniques that increase the sensitivity of breast cancer detection, leading to fewer cancers being missed by doctors.

Dexela has developed world-leading technology for the acquisition, processing and visualisation of high resolution 3-D images of the breast, a type of imaging known as Tomosynthesis. Dexela’s novel approach to Tomosynthesis has significant clinical advantages over competing approaches.